Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 867 | 1058 | 853 | 643 | 982 | 1483 |
Fund Return | -13.34% | 5.77% | -14.66% | -13.68% | -0.36% | 4.02% |
Place in category | - | - | - | - | - | - |
% in Category | - | - | - | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Everbright Pramerica New Growth St | 841.62M | -1.93 | -11.33 | 10.65 | ||
Everbright Pramerica Advantage Allo | 706.84M | 1.88 | -14.71 | 3.01 | ||
Everbright Made In China 2025 Alloc | 617.77M | -4.65 | -7.70 | - | ||
Everbright Pramerica Dividend Stock | 335.83M | -1.15 | -11.48 | 7.89 | ||
Everbright Pramerica Industry Wheel | 314.8M | 4.25 | -9.64 | 14.66 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhong Ou Modern Pioneer InitiatingA | 12.25B | 7.83 | -9.69 | - | ||
TianHong ChiNext Index A | 6.81B | -1.11 | -14.35 | - | ||
TianHong ChiNext Index C | 6.81B | -1.19 | -14.52 | - | ||
ICBC Credit Literary Ids Eq | 5.51B | 6.59 | -8.76 | - | ||
Harvest Emerging Industry Eq | 5.46B | -2.33 | -17.92 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Anhui Huangshan Capsule | CNE100002BV5 | 0.91 | 6.57 | +0.31% | |
Double Arrow A | CNE100000N04 | 0.90 | 7.60 | -1.04% | |
Winbase Chemical A | CNE100000W52 | 0.87 | 5.03 | +0.60% | |
Chengdu Yunda Technology | CNE100001Z33 | 0.78 | 5.79 | +1.40% | |
Tus Pharmaceutical | CNE000000701 | 0.72 | 6.74 | -0.59% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Neutral | Sell |
Technical Indicators | Strong Buy | Strong Buy | Strong Sell |
Summary | Strong Buy | Buy | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review